Effects of the EatWelLog App on Diet Management for Older Adults With Sarcopenic Obesity
NCT06360432 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-02-13
Summary
Sarcopenic obesity, characterised by concurrent reduced muscle mass and excess body fat, affects 11% of older adults worldwide, rising to 23% in those over 75. Considering the negative synergistic impact on health, promoting muscle mass gains while reducing fat mass remains a significant challenge, necessitating urgent and effective intervention strategies for managing SO. Exercise and nutrition are the primary interventions recommended for SO.
This project aims to evaluate the effects of the EatWellLog App developed by the investigators' team for local older adults, in improving:
* their sarcopenic obesity status, measured by all four diagnostic criteria, including grip strength, muscle mass, physical performance and body fat mass (primary outcome), and,
* nutritional self-efficacy, nutritional status, dietary quality, health-related quality of life, and adherence to diet and exercise regimens (secondary outcomes), by enhancing the self-management abilities and longer-term adherence to daily diet management among participants in the M-health group using the App, compared to the control group.
The EatWellLog App, designed for older adults with SO, incorporating Klasnja and Pratt's five-strategy framework for mobile health (mHealth) applications development to facilitate health behavioural change. This App supports users with SO in managing daily diets that promote gradual weight loss and muscle mass preservation, adhering to the dietary regimen for this population.
Forty older adults with SO will be recruited from local community health centres and then randomized to either m-health or control groups. Both groups will receive an 8-week supervised programme separately. The programme consists of personalised dietary modification programme and group-based exercise training which have been tested and used in the investigators' pilot and General Research Fund (GRF) project. Additionally, only the m-health group will be instructed to use the App for daily diet self-management.
Participants will be assessed on a variety of outcomes immediately after the 8-week supervised programme (T1), which will be compared to the baseline (T0). To explore the possible long-term effects of the intervention, other measurements will be conducted at 3-(T2) and 6-(T3) months after the supervised programme, which will be compared with those conducted at T0.
Conditions
- Sarcopenic Obesity
Interventions
- BEHAVIORAL
-
Dietary modification program
Participants will receive an 8-week program consisting of personalized dietary modification program. The dietary modification program is composed of a total of 8 personalized, one-hour face-to-face sessions. Participants will be encouraged to take on a moderate hypocaloric plan that cuts daily energy expenditure to encourage steady weight loss while preserving muscle mass. A protein intake of 1.5 g/kg of body weight per day is recommended. To optimize protein uptake, it's suggested that protein be distributed evenly across meals, aiming for 25-30 g per meal, inclusive of 2.5-2.8 g of leucine. Participants will also receive a guidebook, crafted through the Delphi method, to facilitate the adoption of these dietary modifications in their daily routines.
- BEHAVIORAL
-
Exercise training
Participants will receive an 8-week program consisting of exercise training. It entails weekly group sessions, with each lasting an hour for 8 weeks. These sessions, designed for groups of approximately 10, will blend resistance and aerobic workouts to enhance muscle mass and strength while reducing fat in individuals with SO. Each session includes a 10-minute warm-up and cool-down, 20 minutes of resistance training using elastic bands, followed by a 20-minute brisk walking segment. Participants will also receive a YouTube link and a pamphlet describing the exercises, encouraging them to maintain at least 30 minutes of exercise five times a week during and beyond the supervised programme.
- BEHAVIORAL
-
The EatWellLog App
Only participants in the M-health group will be instructed to use the EatWellLog app for daily diet self-management. This App supports participants with SO by providing a structured approach to managing a diet that encourages steady weight loss while maintaining muscle mass, in line with current nutritional recommendations for this demographic. The EatWellLog App has the following features: i) tracking participants' dietary habits by logging meals and snacks from a food list, ii) personalized online coaching and reminders by a multidisciplinary healthcare team, iii) participation of family caregivers through an interactive messaging function, iv) accessing health information via multiple channels, including animations, an at-a-glance display, and a reminder, and v) utilization of game elements, such as educational animations and video games to disseminate health and nutritional information related to SO.
Sponsors & Collaborators
-
The Hong Kong Polytechnic University
lead OTHER
Principal Investigators
-
Justina Liu, PhD · The Hong Kong Polytechnic University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-08
- Primary Completion
- 2025-09-30
- Completion
- 2025-10-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates
NCT00721227 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Safety and Efficacy of Euiiyin-tang on Obesity
NCT01724099 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Endoscopic Sleeve Gastroplasty Versus GLP-1 Analogue for Class 1 and 2 Obesity Study
NCT05569304 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH
NCT02412540 ·Status: COMPLETED ·Phase: NA
-
Nonsurgical Reversible Obesity Treatment (NROT1)
NCT05420506 ·Status: UNKNOWN ·Phase: NA
-
Chewing, Swallowing and Orofacial Motricity in Severe Obese
NCT05516693 ·Status: UNKNOWN ·Phase: NA
-
SEMASEARCH, Retrospective/Prospective Cohort Nested at ATUc/AP2 WEGOVY®
NCT05897398 ·Status: COMPLETED
-
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss
NCT07237750 ·Status: RECRUITING ·Phase: NA
-
Small Intestinal Submucosa Scaffold Combined With Adipose-derived Stem Cells to Form an Adipocyte-containing Hypodermis
NCT02560350 ·Status: UNKNOWN
-
A Study of the TransPyloric Shuttle™ (TPS™) for Weight Reduction in Obese Subjects
NCT01386905 ·Status: COMPLETED ·Phase: NA
-
Machine Learning for Reclassification of Obesity
NCT04282837 ·Status: COMPLETED
-
Endoscopic Sleeve Gastroplasty for Treatment of Obesity
NCT02231970 ·Status: UNKNOWN ·Phase: NA
-
Aesthetic Analysis of Gluteal Deformity After Weight Loss and Assessment the Role of Autologous Tissue Augmentation for Gluteal Contouring
NCT04167215 ·Status: UNKNOWN ·Phase: NA
-
Endoscopic Bariatric Stapling Pilot Study
NCT01067625 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of Radiofrequency on Located Adiposity
NCT02546778 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Gastric Balloon in Obese Adolescents
NCT04209842 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endostapler Sleeve Gastrectomy Study
NCT04617574 ·Status: COMPLETED
-
Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)
NCT01761370 ·Status: COMPLETED ·Phase: NA
-
Impact of Wearing a Support Garment Following Parietal Gastrectomy
NCT04938310 ·Status: TERMINATED ·Phase: NA
-
Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.
NCT07335731 ·Status: RECRUITING ·Phase: NA
-
Central Obesity in Cases of OAB
NCT03750604 ·Status: COMPLETED ·Phase: NA
-
Study To Evaluate Upper Arm Autologous Fat Transfer
NCT01313000 ·Status: COMPLETED
-
ESG in Obese Adolescents
NCT06914765 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Observation on Obesity Undergoing XOWI
NCT05122936 ·Status: ENROLLING_BY_INVITATION
-
Intragastric Balloon for Treatment of Overweight and Obesity: Which is the Best Filling Volume?
NCT06673550 ·Status: RECRUITING ·Phase: NA